1. Combination of active specific immunotherapy or adoptive antibody or lymphocyte immunotherapy with chemotherapy in the treatment of cancer

   • Tianqian Zhang
   • Dorothee Herlyn

   Review 17 October 2008 Pages: 475 - 492

2. Intravesical administration of γδ T cells successfully prevents the growth of bladder cancer in the murine model

   • Takeshi Yuasa
   • Kiyoshi Sato
   • Shinya Kimura

   Original Article 06 August 2008 Pages: 493 - 502

   

3. Antigen-presenting cells containing multiple costimulatory molecules promote activation and expansion of human antigen-specific memory CD8⁺ T cells

   • Sixun Yang
   • Jeffrey Schlom

   Original Article 09 August 2008 Pages: 503 - 515

   

4. Immune stimulatory antigen loaded particles combined with depletion of regulatory T-cells induce potent tumor specific immunity in a mouse model of melanoma

   • Robin Goforth
   • Aliasger K. Salem
   • Anthony D. Sandler

   Original Article 22 August 2008 Pages: 517 - 530

   

5. Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor

   • Mariangela Figini
   • Franck Martin
   • Silvana Canevari

   Original Article 15 August 2008 Pages: 531 - 546

   

6. Early developmental expression of a normally tumor-associated and drug-inhibited cell surface-located NADH oxidase (ENOX2) in non-cancer cells

   • NaMi Cho
   • D. James Morré

   Original Article 15 August 2008 Pages: 547 - 552

   

7. A fast and efficient HLA multimer-based sorting procedure that induces little apoptosis to isolate clinical grade human tumor specific T lymphocytes

   • Régis Bouquié
   • Annabelle Bonnin
   • François Lang

   Original Article 27 August 2008 Pages: 553 - 566

   

8. Interferon regulatory factor 8 mediates tumor-induced inhibition of antigen processing and presentation by dendritic cells

   • Irina L. Tourkova
   • Galina V. Shurin
   • Michael R. Shurin

   Original Article 28 August 2008 Pages: 567 - 574

   

9. NK1.1⁺ cells mediate the antitumor effects of a dual Toll-like receptor 7/8 agonist in the disseminated B16-F10 melanoma model

   • Calin D. Dumitru
   • Mary A. Antonysamy
   • Gary W. Gullikson

   Original Article 13 September 2008 Pages: 575 - 587

   

10. Treatment of ovarian cancer cell lines with 5-aza-2′-deoxycytidine upregulates the expression of cancer-testis antigens and class I major histocompatibility complex-encoded molecules

    • Sara J. Adair
    • Kevin T. Hogan

    Original Article 13 September 2008 Pages: 589 - 601

    

11. High expression of PGE₂ enzymatic pathways in cervical (pre)neoplastic lesions and functional consequences for antigen-presenting cells

    • Michaël Herfs
    • Ludivine Herman
    • Philippe Delvenne

    Original Article 19 September 2008 Pages: 603 - 614

    

12. Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse

    • Alain P. Vicari
    • Rachel Luu
    • Arthur M. Krieg

    Original Article 19 September 2008 Pages: 615 - 628

    

13. In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells

    • Xiao-ling Lu
    • Xiao-bing Jiang
    • Sheng-min Zhang

    Original Article 06 August 2008 Pages: 629 - 638

    

14. In vivo anti-melanoma efficacy of allo-restricted CTLs specific for melanoma expanded by artificial antigen-presenting cells

    • Xiao-ling Lu
    • Xiao-bing Jiang
    • Zhi-hui Liang

    Erratum 17 October 2008 Pages: 639 - 639